Maria Jesus Citores
Autonomous University of Madrid
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Maria Jesus Citores.
Annals of the Rheumatic Diseases | 2006
Susana Mellor-Pita; Maria Jesus Citores; Raquel Castejon; Pablo Tutor-Ureta; Miguel Yebra-Bango; José Luis Andreu; Juan A. Vargas
Current evidence indicates that regulatory T cells (Tregs) actively suppress autoreactive lymphocytes that escape central tolerance.1,2 Tregs are characterised by a high intensity CD25 constitutive expression3 on the surface of CD4 T lymphocytes, which distinguishes them from the non-regulatory CD4+CD25+ T lymphocytes.4 Because of their important role in the maintenance of tolerance, it has been suggested that Tregs are decreased in patients with systemic lupus erythematosus (SLE).5 We have quantified Tregs in patients with SLE and controls and evaluated their association with disease activity and treatment. Thirty three patients with SLE (26 women, 7 men) and 14 healthy volunteers matched for age and sex (11 women, 3 men) with a mean age of 39.9 and 36 years, respectively, were studied. All patients fulfilled at least four of the American College of Rheumatology 1982 revised criteria for the classification of SLE.6 Disease activity at the time of blood sampling was assessed using the SLE Disease Activity Index (SLEDAI).7 …
Cytometry Part B-clinical Cytometry | 2009
Susana Mellor-Pita; Maria Jesus Citores; Raquel Castejon; Miguel Yebra-Bango; Pablo Tutor-Ureta; Silvia Rosado; José Luis Andreu; Juan A. Vargas
To investigate the contribution of T lymphocytes and monocytes to cytokine production in systemic lupus erythematosus (SLE).
Human Immunology | 2008
Silvia Rosado; Gema Pérez-Chacón; Susana Mellor-Pita; Inmaculada Sanchez-Vegazo; Carmen Bellas-Menendez; Maria Jesus Citores; Ignacio Losada-Fernandez; Trinidad Martin-Donaire; Nerea Rebolleda; Paloma Pérez-Aciego
The purpose of this study was to examine the expression of human leukocyte antigen-G (HLA-G) in patients with systemic lupus erythematosus (SLE) and its relation with interleukin-10 (IL-10) production. The study included 50 female SLE patients and 59 healthy female donors. HLA-G expression in peripheral blood and cutaneous biopsies was determined by flow cytometry and immunohistochemistry, respectively. Soluble HLA-G (sHLA-G) and IL-10 were quantified in serum samples by enzyme-linked immunosorbent assay. SLE patients presented with serum sHLA-G and IL-10 levels significantly higher than that observed in controls (median [interquartile range (IQR)] = 43.6 U/ml [23.2-150.2] vs 26.84 U/ml [6.0-45.2], p = 0.004; and 1.4 pg/ml [0-2.3] vs 0 pg/ml [0-1.5], p = 0.01, respectively). But no correlation was observed between sHLA-G and both IL-10 levels and the disease activity index for SLE patients. The expression of membrane HLA-G in peripheral lymphocytes from SLE patients was low, but higher than in controls (median [IQR] = 1.5% [0.6-1.8] and 0.3% [0.2-0.8], respectively; p = 0.02). Finally, these findings were in accordance with the weak expression of HLA-G in skin biopsies. Despite the fact that patients present higher levels of HLA-G than healthy controls, which suggests a possible relevance of this molecule in SLE, it seems not to be related to IL-10 production or disease activity.
Cytometry Part B-clinical Cytometry | 2006
Pablo Tutor-Ureta; Maria Jesus Citores; Raquel Castejon; Susana Mellor-Pita; Miguel Yebra-Bango; Yolanda Romero; Juan A. Vargas
Not all the patients with sarcoidosis need pharmacological therapy, and the decision to start therapy is based mainly on clinical conditions. The aim of this study was to evaluate the prognostic value of the leukocyte and lymphocyte subpopulations in the bronchoalveolar lavage fluid from these patients.
Cytometry Part B-clinical Cytometry | 2003
A. Gallego; Juan A. Vargas; Raquel Castejon; Maria Jesus Citores; Yolanda Romero; I. Millán; A. Durántez
Recent evidence indicates that the slowly expanding population of CD5+ B cells that characterizes B‐cell chronic lymphocytic leukemia (B‐CLL) could be related to defects in the response to cytokine produced by T cells that regulate apoptosis. We studied the intracellular expressions of interleukin‐2 (IL‐2), tumor necrosis factor‐α (TNF‐α), and interferon‐γ (IFN‐γ) in T‐helper 1 cells (Th1 response) of B‐CLL.
Cytometry Part B-clinical Cytometry | 2003
A. Gallego; Juan A. Vargas; Raquel Castejon; Maria Jesus Citores; Yolanda Romero; I. Millán; A. Durántez
Recent evidence indicates that the slowly expanding population of CD5+ B cells that characterizes B‐cell chronic lymphocytic leukemia (B‐CLL) could be related to defects in the response to cytokine produced by T cells that regulate apoptosis. We studied the intracellular expressions of interleukin‐2 (IL‐2), tumor necrosis factor‐α (TNF‐α), and interferon‐γ (IFN‐γ) in T‐helper 1 cells (Th1 response) of B‐CLL.
The American Journal of the Medical Sciences | 2009
Carlos García-Zubiri; Maria Jesus Citores; Miguel Yebra-Bango
Cardiac myxoma cells have been demonstrated to produce interleukin (IL)-6, but its role in the systemic and immunologic manifestations of patients with this tumor is controversial. There is no evidence of any other source of such cytokine, but here we report a case of myxoma with systemic manifestations at diagnosis in which we evaluated the IL-6 production by peripheral blood cells before and after surgical tumor resection. Peripheral blood mononuclear cells were isolated by density gradient centrifugation, and the IL-6 expression in monocytes and lymphocytes was evaluated by flow cytometry. Before surgery, 74.4% of monocytes produced IL-6, but 1 month after surgery, a decrease in both the number of monocytes and the percentage of these cells expressing IL-6 was found along with an improvement of systemic and immunologic manifestations. Here, we demonstrated for the first time that monocytes contribute to the elevated production of IL-6 in patients with myxoma.
Experimental Hematology | 2010
Maria Jesus Citores; Raquel Castejon; Mercedes Villarreal; Silvia Rosado; José A. García-Marco; Juan A. Vargas
OBJECTIVE Despite a fludarabine-based treatment is the first choice of therapy in chronic lymphocytic leukemia (CLL), not all patients achieve a partial or complete response and some of them develop autoimmune manifestations. The aim of this study was to evaluate the influence of CD154 on these adverse effects because CD154 is involved in both B-cell survival and autoimmunity. MATERIALS AND METHODS Peripheral blood mononuclear cells (PBMC) from 36 patients with CLL were cultured in vitro with fludarabine or 2-chlorodeoxyadenosine for 24, 48, and 72 hours. RESULTS Seven patients (19.4%) presented CD154 expression in PBMC cultured with purine analogues in vitro for 24 and/or 48 hours, while no expression was found when cultured in media alone. These seven patients showed a decreased apoptotic rate in vitro after purine analogues compared with those patients who did not express CD154 (p = 0.01 for fludarabine; p < 0.001 for 2-chlorodeoxyadenosine). CD154 expression was found to have prognostic value for response to fludarabine in vivo and was associated with the development of autoimmune manifestations (odds ratio = 25; 95% confidence interval = 3.5-166.7; p < 0.001). CONCLUSION Our preliminary results suggest that CD154 expression in CLL patients, which may be induced by purine analogues, is associated with resistance to fludarabine and with development of autoimmune manifestations.
Gene | 2016
Elena Martínez-Robles; Miguel Yebra-Bango; Susana Mellor-Pita; Pablo Tutor-Ureta; Juan A. Vargas; Maria Jesus Citores
Genetic variants of endosomal toll like receptors (TLR) have been associated with many infectious, autoimmune and inflammatory diseases, but few studies have been reported in the Spanish population. The aim of this study was to describe the allelic and genotypic distributions of some common nucleotide substitutions of endosomal TLRs in healthy Spanish women and to compare them with those already published in other population groups. Nine substitutions were analysed in 150 DNA samples from 150 Spanish, non-related healthy females: TLR3 rs3775291 and rs5743305; TLR7 rs179008 and rs5743781; TLR8 rs3764880 and TLR9 rs187084, rs5743836, rs352139 and rs352140. Genotyping was carried out by real time PCR and melting curve analysis in a LightCycler 480. A systematic review was performed in order to compare the genotypic distributions in our cohort with those previously published in other population groups. The comparative study was performed with the two tailed Fishers test or the Yates continuity correction for the Chi-square test when appropriate. No homozygotes for rs5743781 in TLR7 were found, and rs352139 and rs352140 of TLR9 were in strong linkage disequilibrium. Genotype distributions in endosomal TLR are similar to other Spanish series previously reported. As expected, most differences were found when comparing our distributions with Asiatics, but differences were also found with other Caucasian populations. Since there are significant variations in genotypic distributions of TLRs in both interracial groups and within the same ethnic group, to carry out studies of disease susceptibility in more restricted groups is mandatory.
Seminars in Arthritis and Rheumatism | 2007
Mónica Fernández-Castro; Susana Mellor-Pita; Maria Jesus Citores; Pilar Muñoz; Pablo Tutor-Ureta; Lucia Silva; Juan A. Vargas; Miguel Yebra-Bango; José Luis Andreu